Adenocarcinoma in Situ of the Cervix: Sensitivity of Detection by Cervical Smear: Will Cytologic Screening for Adenocarcinoma in Situ Reduce Incidence Rates for Adenocarcinoma?

Cancer

Volumn 96, Issue 6, 2002, Pages 319-322

  Smith, Harriet O ^a   Padilla, Luis A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; AUSTRALIA; CARCINOMA IN SITU; EDITORIAL; INCIDENCE; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADENOCARCINOMA; AUSTRALIA; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0037176177     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10887     Document Type: Review

References (20)

1. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol. 1995;85:1017-1021.
2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the U.S. - A 24-year population-based study. Gynecol Oncol. 2000;78:97-105.
3. Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 2001;357:1490-1493.
4. Alfsen GC, Thoresen SO, Kristensen GB, Skovlund E, Abeler VM. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer. 2000;89:1291-1299.
5. Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer. 2001;11:24-31.
6. Sigurdsson K. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand. 1999;78:478-485.
7. Herbert A, Singh N, Smith JAE. Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: a 12-year study in Southampton and South-west Hampshire. Cytopathology. 2001;12:26-36.
8. Schoolland M, Segal A, Allpress S, Miranda A, Frost FA, Sterrett GF. Adenocarcinoma in situ of the cervix: sensitivity of detection by cervical smear. Cancer (Cancer Cytopathol). 2002;96:330-337.
9. Wright TC Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
10. Krivak TC, Rose GS, McBroom JW, Carlson JW, Winter WE III, Kost ER. Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease. Obstet Gynecol Surv. 2001;56:567-575.
11. Zaino RJ. Glandular lesions of the uterine cervix. Mod Pathol. 2000;13:261-274.
12. Goldstein NS, Ahmad E, Hussain M, Hankin RC, Perez-Reyes N. Endocervical glandular atypia: does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol. 1998;110:200-209.
13. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol. 2001;82:516-522.
14. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer. 2000;90(4):207-214.
15. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol. 2000;182:1278-1282.
16. Chhieng DC, Elgert P, Cohen JM, Cangiarella JF. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer. 2001;93:1-7.
17. Schoolland M, Allpress S, Sterrett GF. Adenocarcinoma of the cervix: sensitivity of diagnosis by cervical smear and cytologic patterns and pitfalls in 24 cases. Cancer (Cancer Cytopathol). 2002;96:5-13.
18. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
19. Plaxe SC, Saltzstein SL. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol. 1999;75:55-61.
20. Romero AA, Key CR, Smith HO. Changing trends in the incidence rates for ADC (adenocarcinoma) and SCC (squamous cell carcinoma) incidence rates by age, race, and stage: a 25-year population-based study. Gynecol Oncol. 2001;80:295-296.